Acquiring Company
AbbVie
Acquired Company
Apogee Therapeutics
WalthamresearchDescription
AbbVie has completed its acquisition of Apogee Therapeutics, adding zumilokibart for atopic dermatitis and a combination programme for asthma to its immunology pipeline. The company reaffirmed its full-year and latest-quarter earnings guidance in the release. Management expects the deal to dilute adjusted earnings per share for several years before it turns accretive.
Who to call at AbbVie, and when
When AbbVie changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Apogee Therapeutics?
Apogee Therapeutics was acquired by AbbVie. The deal was reported on October 28, 2026. AbbVie is privately held.
When did AbbVie acquire Apogee Therapeutics?
AbbVie's acquisition of Apogee Therapeutics was reported on October 28, 2026. AbbVie has completed its acquisition of Apogee Therapeutics, adding zumilokibart for atopic dermatitis and a combination programme for asthma to its immunology pipeline. The company reaffirmed its full-year and latest-quarter earnings guidance in the release. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Apogee Therapeutics do?
Apogee Therapeutics is a clinical-stage biotechnology company dedicated to developing innovative biologic therapies for inflammatory and immunology diseases. It is privately held, operating in research, and is based in Waltham.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.